These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus. Hammond SA; Raabe ML; Issel CJ; Montelaro RC Virology; 1999 Sep; 262(2):416-30. PubMed ID: 10502520 [TBL] [Abstract][Full Text] [Related]
24. [HIV: virology and vaccination]. Löwer J; Norley SG; Kraus G; Werner A; Kurth R Verh Dtsch Ges Inn Med; 1988; 94():537-42. PubMed ID: 3061230 [No Abstract] [Full Text] [Related]
25. Development of new vaccines for AIDS. Garrison L; Clements ML Compr Ther; 1989 Jul; 15(7):47-55. PubMed ID: 2670404 [No Abstract] [Full Text] [Related]
26. [Development of viral vaccines]. Mertens T Immun Infekt; 1987 Nov; 15(6):197-202. PubMed ID: 3325407 [TBL] [Abstract][Full Text] [Related]
27. [Advances in AIDS vaccines]. Piédrola Angulo G An R Acad Nac Med (Madr); 1992; 109(3):531-50. PubMed ID: 1284508 [No Abstract] [Full Text] [Related]
28. Phase I trial of potential AIDS vaccine commences. Oncology (Williston Park); 1991 May; 5(5):182. PubMed ID: 1832002 [No Abstract] [Full Text] [Related]
33. HIV/AIDS in China. Vaccine development with a distinctly Chinese flavor. Cohen J Science; 2004 Jun; 304(5676):1437. PubMed ID: 15178780 [No Abstract] [Full Text] [Related]
34. Canadian lab to produce HIV immunogen for clinical trials. CMAJ; 1990 Nov; 143(9):907. PubMed ID: 2224719 [No Abstract] [Full Text] [Related]
35. Prediction of HIV vaccine. Robson B; Fishleigh RV; Morrison CA Nature; 1987 Jan 29-Feb 4; 325(6103):395. PubMed ID: 3468356 [No Abstract] [Full Text] [Related]
36. Summary of the SIV Working Group. Schultz AM AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1439-40. PubMed ID: 1466977 [No Abstract] [Full Text] [Related]
37. The iscom antigen-presenting system. Morein B Nature; 1988 Mar; 332(6161):287-8. PubMed ID: 3347272 [TBL] [Abstract][Full Text] [Related]
38. [Analysis on the immuno-effects of two different Japanese encephalitis virus vaccines]. Guo W; Li L; Wu Z Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Apr; 19(2):97-9. PubMed ID: 10322719 [TBL] [Abstract][Full Text] [Related]
39. [Vaccinations and systemic diseases. Vaccinations and immunosuppression]. Bouchaud O; Mouas H Ann Med Interne (Paris); 1998 Oct; 149(6):351-60. PubMed ID: 9853045 [TBL] [Abstract][Full Text] [Related]
40. [The status of research to develop new vaccines against infection caused by the respiratory syncytial virus]. Pervikov IuV; Litvinov SK Vopr Virusol; 1988; 33(5):523-9. PubMed ID: 3064426 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]